BMW Korea launched the first plug-in hybrid electric vehicle (PHEV) in the M high-performance lineup, the XM.
The M hybrid system in the XM intelligently controls the interaction between the engine and motor.
A 197-horsepower electric motor and the new M Twin Power Turbo technology were paired with a 489-horsepower high-revving V8 gasoline engine to give a combined output of 653 horses and a maximum torque of 81.6 kilogram-meters.
It takes 4.3 seconds to accelerate from zero to 100 km/h.
This vehicle is equipped with a high-voltage battery with a capacity of 29.5 kilowatt-hours and can travel 62 km in a pure electric mode, according to the standards set by the Ministry of Environment. The top speed in electric mode is 140 km/h. It takes about 4.2 hours to fully charge the battery and the mileage comes at 10.0 km per liter.
The BMW XM is priced at 221.9 million won.


Wall Street Slides as Iran War Uncertainty, Oil Surge, and AI Fears Rattle Markets
Henkel in Advanced Talks to Acquire Olaplex at $2 Per Share
Trump Tariffs Show Minimal Economic Impact but Boost Federal Revenue, Study Finds
The Beauty Beneath the Expressway: A Journey from Self to Service
Goldman Sachs Raises ECB Rate Hike Forecast Amid Persistent Energy-Driven Inflation
U.S. Oil Prices Slide as Middle East Ceasefire Talks Spark Market Optimism
What’s the difference between baking powder and baking soda? It’s subtle, but significant
Valero Port Arthur Refinery Explosion Prompts $1M Lawsuit Over Worker Safety Negligence
Glastonbury is as popular than ever, but complaints about the lineup reveal its generational challenge
Bank of Japan Unveils New Inflation Gauge to Support Case for Future Rate Hikes
Delivery Hero Sells Taiwan Foodpanda to Grab for $600 Million in Debt-Reduction Push
Asian Currencies Stay Muted as Dollar Holds Firm Amid Iran Uncertainty
Asian Currencies Weaken as Dollar Rebounds Amid Middle East Uncertainty and Japan Inflation Data
Currency Markets Show Caution Amid U.S.-Iran Negotiations
Australia-EU Free Trade Deal Signed After Years of Negotiations
Innate Pharma Reports 55% Revenue Drop and €49.2M Net Loss for 2025 



